What is the Impact Factor of Artificial Cells Nanomedicine and Biotechnology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Artificial Cells Nanomedicine and Biotechnology is 5.60, ranking in quartile Q1 of Web of Science (SCIE).

Is Artificial Cells Nanomedicine and Biotechnology indexed in Web of Science or Scopus?

Yes, Artificial Cells Nanomedicine and Biotechnology is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.967 (Q1) and an H-index of 105.

Who publishes Artificial Cells Nanomedicine and Biotechnology and what is the Article Processing Charge (APC)?

Artificial Cells Nanomedicine and Biotechnology is published by Informa Healthcare. The estimated Article Processing Charge (APC) is approximately $3,195 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Artificial Cells Nanomedicine and Biotechnology?

The official ISO-4 abbreviation of Artificial Cells Nanomedicine and Biotechnology is "ARTIF CELL NANOMED B" with common acronym "labb". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #5,164Hybrid

Artificial Cells Nanomedicine and Biotechnology

Acronym:labb

•

Abbreviation (ISO):ARTIF CELL NANOMED B

•

Identifier (ISSN):2169-1401(Print)/2169-141X(Online)

•

Publisher:Informa Healthcare

Official Website Submission Portal Compare

Clarivate IF (2026)

5.6↑ +1.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Artificial Cells Nanomedicine and Biotechnology

WoS Q1

Annual Impact Factor Metric

Current (2026):5.6

Scopus SJR & RankScopus Q1

0.967

#5,164

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

105

105 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate2.2%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

60articles/year

99.25% Gold OA•100% Original Research

Aims & Scope

Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:artificial cellsblood substitutes and oxygen therapeuticsnanotechnology, nanobiotecnology, nanomedicinetissue engineeringstem cellsbioencapsulationmicroencapsulation and nanoencapsulationmicroparticles and nanoparticlesliposomescell therapy and gene therapyenzyme therapydrug delivery systemsbiodegradable and biocompatible polymers for scaffolds and carriersbiosensorsimmobilized enzymes and their usesother biotechnological and nanobiotechnological approachesRapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.

Topics Covered (Recognized by AI)

BiologyChemistryMedicineBiochemistryGeneticsMaterials ScienceInternal MedicineOrganic ChemistryPhysicsNanotechnologyEngineeringChemical EngineeringQuantum MechanicsPharmacologyPathologyImmunologyCell BiologyCancer ResearchNuclear Magnetic ResonanceComposite Materials

Primary Research Areas

Biotechnology & Applied Microbiology Engineering Biomedical

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Rank38/180

IndexSCIE

JCRSCIE2026

ENGINEERING, BIOMEDICAL

Rank34/130

IndexSCIE

JCRSCIE2026

MATERIALS SCIENCE, BIOMATERIALS

Rank21/58

IndexSCIE

JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Rank50/180

IndexSCIE

JCISCIE2026

ENGINEERING, BIOMEDICAL

Rank34/130

IndexSCIE

JCISCIE2026

MATERIALS SCIENCE, BIOMATERIALS

Rank17/58

IndexSCIE

Category	Index	Rank	Quartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCRSCIE	38/180	Q1
ENGINEERING, BIOMEDICAL	JCRSCIE	34/130	Q2
MATERIALS SCIENCE, BIOMATERIALS	JCRSCIE	21/58	Q2
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCISCIE	50/180	Q2
ENGINEERING, BIOMEDICAL	JCISCIE	34/130	Q2
MATERIALS SCIENCE, BIOMATERIALS	JCISCIE	17/58	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF5.6

Articles / Year50

Total Citations28

2025

IF4.5

Articles / Year54

Total Citations165

2024

IF4.5

Articles / Year43

Total Citations485

2023

IF5.8

Articles / Year61

Total Citations967

2022

IF6.355

Articles / Year55

Total Citations531

Year	Impact Factor	Articles / Year	Total Citations
2026	5.6	50	28
2025	4.5	54	165
2024	4.5	43	485
2023	5.8	61	967
2022	6.355	55	531
2021	5.678	132	1,618
2020	3.343	168	2,834
2019	4.462	521	19,597
2018	3.026	341	14,300
2017	—	265	14,951
2016	—	196	9,440
2015	—	155	4,894

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,164Scopus Q1SCImago Profile

Scopus Coverage:2013-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyEngineeringMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

0.967

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

6.26

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,195 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations781

3-Year Documents130

Citable Documents129

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiotechnologyQ1

Medicine (miscellaneous)Q1

Pharmaceutical ScienceQ1

Biomedical EngineeringQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Biology

Minor Category (Specific Field):

2区BIOTECHNOLOGY & APPLIED MICROBIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

In warning list

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Artificial Cells Nanomedicine and Biotechnology (acronym: labb, abbr: ARTIF CELL NANOMED B, ISSN: 2169-1401) is a peer-reviewed international scholarly journal in the field of BIOTECHNOLOGY & APPLIED MICROBIOLOGY, published by Informa Healthcare in United States. The periodical holds a Journal Impact Factor (JIF) of 5.60, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 0.967 (Q1), an H-index of 105.

The journal enforces rigorous peer evaluation with an annual output of approximately 60 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,195 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.